JPMorgan Chase & Co. boosted its holdings in Globe Life Inc. (NYSE:GL – Free Report) by 11.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 247,947 shares of the company’s stock after acquiring an additional 24,785 shares during the quarter. JPMorgan Chase & Co.’s holdings in Globe Life were worth $35,449,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Intech Investment Management LLC boosted its position in Globe Life by 0.8% during the 2nd quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock worth $1,438,000 after acquiring an additional 95 shares during the period. CX Institutional grew its stake in shares of Globe Life by 5.6% in the third quarter. CX Institutional now owns 1,805 shares of the company’s stock worth $258,000 after purchasing an additional 96 shares in the last quarter. Laird Norton Wetherby Wealth Management LLC increased its holdings in shares of Globe Life by 2.2% during the third quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after purchasing an additional 99 shares during the period. KLP Kapitalforvaltning AS raised its stake in shares of Globe Life by 0.5% during the third quarter. KLP Kapitalforvaltning AS now owns 22,000 shares of the company’s stock valued at $3,145,000 after purchasing an additional 100 shares in the last quarter. Finally, Clearstead Advisors LLC raised its stake in shares of Globe Life by 1.9% during the third quarter. Clearstead Advisors LLC now owns 5,273 shares of the company’s stock valued at $754,000 after purchasing an additional 100 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages recently issued reports on GL. Truist Financial increased their target price on shares of Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, February 6th. TD Cowen restated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. JPMorgan Chase & Co. upped their price target on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Morgan Stanley reiterated an “overweight” rating and set a $176.00 price objective on shares of Globe Life in a research note on Monday, December 15th. Finally, Evercore set a $157.00 target price on Globe Life in a report on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus price target of $171.33.
Globe Life Price Performance
NYSE:GL opened at $136.85 on Monday. The business’s 50-day moving average price is $141.82 and its 200 day moving average price is $138.94. The firm has a market cap of $10.73 billion, a P/E ratio of 9.72 and a beta of 0.46. Globe Life Inc. has a 52-week low of $109.38 and a 52-week high of $152.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.39.
Globe Life (NYSE:GL – Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the company posted $3.14 earnings per share. Globe Life’s revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, sell-side analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.
Globe Life Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Thursday, April 2nd. This is an increase from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s payout ratio is presently 7.67%.
Insider Buying and Selling at Globe Life
In related news, CEO James Matthew Darden sold 18,318 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $145.10, for a total transaction of $2,657,941.80. Following the completion of the sale, the chief executive officer directly owned 51,093 shares in the company, valued at approximately $7,413,594.30. This trade represents a 26.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Mark A. Blinn sold 1,750 shares of Globe Life stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the transaction, the director owned 3,372 shares in the company, valued at approximately $498,752.52. This trade represents a 34.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 82,807 shares of company stock valued at $12,041,286. Corporate insiders own 1.97% of the company’s stock.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Articles
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
